{"entity":{"type":"insider","cik":"0001577034","url":"/insider/0001577034","json_url":"/insider/0001577034.json","name":"Gould Robert J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":58,"n_filings":35,"first":"2014-01-06","last":"2026-02-04","span_basis":"filed_date"},"name_variants":[{"name":"Gould Robert J","source":"filing","n_filings":35,"first_seen":"2014-01-06","last_seen":"2026-02-04"}],"transactions":[{"id":6072613,"accession":"0001193125-26-037573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-037573","line_url":"/filing/0001193125-26-037573#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":10.7238,"price_display":"10.72","price_state":"stated","total_value":160857.0,"total_display":"160,857.00","shares_owned_after":454864.0,"shares_owned_after_display":"454,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":9255170,"accession":"0001193125-26-037606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-037606","line_url":"/filing/0001193125-26-037606#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":10.8726,"price_display":"10.87","price_state":"stated","total_value":163089.0,"total_display":"163,089.00","shares_owned_after":469864.0,"shares_owned_after_display":"469,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-02-04","scope":"insider"},{"id":6228168,"accession":"0001193125-26-004572","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-004572","line_url":"/filing/0001193125-26-004572#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":11.8726,"price_display":"11.87","price_state":"stated","total_value":178089.0,"total_display":"178,089.00","shares_owned_after":469864.0,"shares_owned_after_display":"469,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-06","scope":"insider"},{"id":4673047,"accession":"0001193125-25-291392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-291392","line_url":"/filing/0001193125-25-291392#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":11.033,"price_display":"11.03","price_state":"stated","total_value":165495.0,"total_display":"165,495.00","shares_owned_after":484864.0,"shares_owned_after_display":"484,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-21","scope":"insider"},{"id":8387791,"accession":"0000899243-23-001803","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001803","line_url":"/filing/0000899243-23-001803#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (Interim President & CEO)","officer_title":"Interim President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6766.0,"shares_display":"6,766","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":101490.0,"total_display":"101,490.00","shares_owned_after":499864.0,"shares_owned_after_display":"499,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-13","filed_date":"2023-01-13","scope":"insider"},{"id":6386144,"accession":"0000899243-22-021530","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-021530","line_url":"/filing/0000899243-22-021530#line-2","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71435.0,"shares_display":"71,435","price_per_share":8.0898,"price_display":"8.09","price_state":"stated","total_value":577894.863,"total_display":"577,894.86","shares_owned_after":506630.0,"shares_owned_after_display":"506,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-07","filed_date":"2022-06-08","scope":"insider"},{"id":6502643,"accession":"0000899243-22-021250","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-021250","line_url":"/filing/0000899243-22-021250#line-6","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24382.0,"shares_display":"24,382","price_per_share":8.104,"price_display":"8.10","price_state":"stated","total_value":197591.728,"total_display":"197,591.73","shares_owned_after":506630.0,"shares_owned_after_display":"506,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-06","scope":"insider"},{"id":6502636,"accession":"0000899243-22-021250","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-021250","line_url":"/filing/0000899243-22-021250#line-4","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25551.0,"shares_display":"25,551","price_per_share":7.9471,"price_display":"7.95","price_state":"stated","total_value":203056.3521,"total_display":"203,056.35","shares_owned_after":506630.0,"shares_owned_after_display":"506,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-06","scope":"insider"},{"id":6502632,"accession":"0000899243-22-021250","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-021250","line_url":"/filing/0000899243-22-021250#line-2","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16689.0,"shares_display":"16,689","price_per_share":7.9191,"price_display":"7.92","price_state":"stated","total_value":132161.8599,"total_display":"132,161.86","shares_owned_after":506630.0,"shares_owned_after_display":"506,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-06","scope":"insider"},{"id":6385767,"accession":"0000899243-22-014438","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-014438","line_url":"/filing/0000899243-22-014438#line-2","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5631.0,"shares_display":"5,631","price_per_share":24.015,"price_display":"24.02","price_state":"stated","total_value":135228.465,"total_display":"135,228.46","shares_owned_after":506630.0,"shares_owned_after_display":"506,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-07","filed_date":"2022-04-11","scope":"insider"},{"id":6620090,"accession":"0000899243-22-013881","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-013881","line_url":"/filing/0000899243-22-013881#line-6","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52552.0,"shares_display":"52,552","price_per_share":24.2574,"price_display":"24.26","price_state":"stated","total_value":1274774.8848,"total_display":"1,274,774.88","shares_owned_after":506630.0,"shares_owned_after_display":"506,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-05","filed_date":"2022-04-05","scope":"insider"},{"id":6620084,"accession":"0000899243-22-013881","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-013881","line_url":"/filing/0000899243-22-013881#line-4","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7235.0,"shares_display":"7,235","price_per_share":24.0151,"price_display":"24.02","price_state":"stated","total_value":173749.2485,"total_display":"173,749.25","shares_owned_after":506630.0,"shares_owned_after_display":"506,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-05","scope":"insider"},{"id":6620079,"accession":"0000899243-22-013881","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-013881","line_url":"/filing/0000899243-22-013881#line-2","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34464.0,"shares_display":"34,464","price_per_share":24.0297,"price_display":"24.03","price_state":"stated","total_value":828159.5808,"total_display":"828,159.58","shares_owned_after":506630.0,"shares_owned_after_display":"506,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-05","scope":"insider"},{"id":4920860,"accession":"0000899243-21-012179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-012179","line_url":"/filing/0000899243-21-012179#line-2","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":789.0,"shares_display":"789","price_per_share":12.4279,"price_display":"12.43","price_state":"stated","total_value":9805.6131,"total_display":"9,805.61","shares_owned_after":506630.0,"shares_owned_after_display":"506,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-16","filed_date":"2021-03-17","scope":"insider"},{"id":4920849,"accession":"0000899243-21-012179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-012179","line_url":"/filing/0000899243-21-012179#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9211.0,"shares_display":"9,211","price_per_share":12.1347,"price_display":"12.13","price_state":"stated","total_value":111772.7217,"total_display":"111,772.72","shares_owned_after":507419.0,"shares_owned_after_display":"507,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":4973351,"accession":"0000899243-21-007119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-007119","line_url":"/filing/0000899243-21-007119#line-2","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6542.0,"shares_display":"6,542","price_per_share":14.1899,"price_display":"14.19","price_state":"stated","total_value":92830.3258,"total_display":"92,830.33","shares_owned_after":518303.0,"shares_owned_after_display":"518,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":4973346,"accession":"0000899243-21-007119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-007119","line_url":"/filing/0000899243-21-007119#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1673.0,"shares_display":"1,673","price_per_share":14.5649,"price_display":"14.56","price_state":"stated","total_value":24367.0777,"total_display":"24,367.08","shares_owned_after":516630.0,"shares_owned_after_display":"516,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":4973162,"accession":"0000899243-21-002928","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-002928","line_url":"/filing/0000899243-21-002928#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.0826,"price_display":"12.08","price_state":"stated","total_value":120826.0,"total_display":"120,826.00","shares_owned_after":524845.0,"shares_owned_after_display":"524,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-20","filed_date":"2021-01-22","scope":"insider"},{"id":2507222,"accession":"0000899243-20-018815","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-018815","line_url":"/filing/0000899243-20-018815#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","shares_owned_after":534845.0,"shares_owned_after_display":"534,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-08","filed_date":"2020-07-09","scope":"insider"},{"id":2101004,"accession":"0000899243-20-017758","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-017758","line_url":"/filing/0000899243-20-017758#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":20.7968,"price_display":"20.80","price_state":"stated","total_value":51992.0,"total_display":"51,992.00","shares_owned_after":537345.0,"shares_owned_after_display":"537,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-25","filed_date":"2020-06-26","scope":"insider"},{"id":2952913,"accession":"0000899243-20-015959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-015959","line_url":"/filing/0000899243-20-015959#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":156.0,"shares_display":"156","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":3120.0,"total_display":"3,120.00","shares_owned_after":539845.0,"shares_owned_after_display":"539,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-10","scope":"insider"},{"id":2169140,"accession":"0000899243-20-015784","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-015784","line_url":"/filing/0000899243-20-015784#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3433.0,"shares_display":"3,433","price_per_share":20.1722,"price_display":"20.17","price_state":"stated","total_value":69251.1626,"total_display":"69,251.16","shares_owned_after":540001.0,"shares_owned_after_display":"540,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-05","filed_date":"2020-06-09","scope":"insider"},{"id":2592964,"accession":"0000899243-20-015437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-015437","line_url":"/filing/0000899243-20-015437#line-2","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":20.0446,"price_display":"20.04","price_state":"stated","total_value":26057.98,"total_display":"26,057.98","shares_owned_after":543434.0,"shares_owned_after_display":"543,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-05","scope":"insider"},{"id":2592958,"accession":"0000899243-20-015437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-015437","line_url":"/filing/0000899243-20-015437#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":20.1283,"price_display":"20.13","price_state":"stated","total_value":30192.45,"total_display":"30,192.45","shares_owned_after":544734.0,"shares_owned_after_display":"544,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-05","scope":"insider"},{"id":2375890,"accession":"0000899243-20-015063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-015063","line_url":"/filing/0000899243-20-015063#line-2","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2797.0,"shares_display":"2,797","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":55940.0,"total_display":"55,940.00","shares_owned_after":546234.0,"shares_owned_after_display":"546,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-03","scope":"insider"},{"id":2375886,"accession":"0000899243-20-015063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-015063","line_url":"/filing/0000899243-20-015063#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5.0,"shares_display":"5","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":100.0,"total_display":"100.00","shares_owned_after":549031.0,"shares_owned_after_display":"549,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-03","scope":"insider"},{"id":3161524,"accession":"0000899243-20-014721","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-014721","line_url":"/filing/0000899243-20-014721#line-2","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1390.0,"shares_display":"1,390","price_per_share":20.0797,"price_display":"20.08","price_state":"stated","total_value":27910.783,"total_display":"27,910.78","shares_owned_after":549036.0,"shares_owned_after_display":"549,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-29","filed_date":"2020-06-01","scope":"insider"},{"id":3161515,"accession":"0000899243-20-014721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-014721","line_url":"/filing/0000899243-20-014721#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1919.0,"shares_display":"1,919","price_per_share":20.0058,"price_display":"20.01","price_state":"stated","total_value":38391.1302,"total_display":"38,391.13","shares_owned_after":550426.0,"shares_owned_after_display":"550,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-28","filed_date":"2020-06-01","scope":"insider"},{"id":2100828,"accession":"0000899243-20-014415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-014415","line_url":"/filing/0000899243-20-014415#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","shares_owned_after":552345.0,"shares_owned_after_display":"552,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-28","scope":"insider"},{"id":2772195,"accession":"0000899243-20-005300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-005300","line_url":"/filing/0000899243-20-005300#line-1","is_derivative":false,"issuer_cik":"0001577034","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001577034","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","shares_owned_after":554845.0,"shares_owned_after_display":"554,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-19","filed_date":"2020-02-20","scope":"insider"},{"id":8805089,"accession":"0001209191-15-087452","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-087452","line_url":"/filing/0001209191-15-087452#line-4","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11805.0,"shares_display":"11,805","price_per_share":18.0189,"price_display":"18.02","price_state":"stated","total_value":212713.1145,"total_display":"212,713.11","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-30","filed_date":"2015-12-31","scope":"insider"},{"id":8805087,"accession":"0001209191-15-087452","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-087452","line_url":"/filing/0001209191-15-087452#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director","officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20303.0,"shares_display":"20,303","price_per_share":18.0081,"price_display":"18.01","price_state":"stated","total_value":365618.4543,"total_display":"365,618.45","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-29","filed_date":"2015-12-31","scope":"insider"},{"id":8803391,"accession":"0001209191-15-070228","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-070228","line_url":"/filing/0001209191-15-070228#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59300.0,"shares_display":"59,300","price_per_share":19.8696,"price_display":"19.87","price_state":"stated","total_value":1178267.28,"total_display":"1,178,267.28","shares_owned_after":700.0,"shares_owned_after_display":"700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-08","filed_date":"2015-09-10","scope":"insider"},{"id":8803390,"accession":"0001209191-15-070228","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-070228","line_url":"/filing/0001209191-15-070228#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":19.25,"price_display":"19.25","price_state":"stated","total_value":13475.0,"total_display":"13,475.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-08","filed_date":"2015-09-10","scope":"insider"},{"id":8696151,"accession":"0001209191-15-064237","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-064237","line_url":"/filing/0001209191-15-064237#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55800.0,"shares_display":"55,800","price_per_share":21.9405,"price_display":"21.94","price_state":"stated","total_value":1224279.9,"total_display":"1,224,279.90","shares_owned_after":4200.0,"shares_owned_after_display":"4,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-05","scope":"insider"},{"id":8696149,"accession":"0001209191-15-064237","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-064237","line_url":"/filing/0001209191-15-064237#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4200.0,"shares_display":"4,200","price_per_share":22.3986,"price_display":"22.40","price_state":"stated","total_value":94074.12,"total_display":"94,074.12","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-05","scope":"insider"},{"id":8417062,"accession":"0001209191-15-060141","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-060141","line_url":"/filing/0001209191-15-060141#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44858.0,"shares_display":"44,858","price_per_share":23.0739,"price_display":"23.07","price_state":"stated","total_value":1035049.0062,"total_display":"1,035,049.01","shares_owned_after":15142.0,"shares_owned_after_display":"15,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-06","filed_date":"2015-07-08","scope":"insider"},{"id":8417056,"accession":"0001209191-15-060141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-060141","line_url":"/filing/0001209191-15-060141#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15142.0,"shares_display":"15,142","price_per_share":23.6449,"price_display":"23.64","price_state":"stated","total_value":358031.0758,"total_display":"358,031.08","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-06","filed_date":"2015-07-08","scope":"insider"},{"id":6476856,"accession":"0001209191-14-066376","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-066376","line_url":"/filing/0001209191-14-066376#line-4","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24094.0,"shares_display":"24,094","price_per_share":24.7735,"price_display":"24.77","price_state":"stated","total_value":596892.709,"total_display":"596,892.71","shares_owned_after":5906.0,"shares_owned_after_display":"5,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider"},{"id":6476854,"accession":"0001209191-14-066376","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-066376","line_url":"/filing/0001209191-14-066376#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5506.0,"shares_display":"5,506","price_per_share":25.6364,"price_display":"25.64","price_state":"stated","total_value":141154.0184,"total_display":"141,154.02","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider"},{"id":6476850,"accession":"0001209191-14-066376","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-066376","line_url":"/filing/0001209191-14-066376#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":26.4416,"price_display":"26.44","price_state":"stated","total_value":10576.64,"total_display":"10,576.64","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider"},{"id":6531457,"accession":"0001209191-14-061878","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-061878","line_url":"/filing/0001209191-14-061878#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29500.0,"shares_display":"29,500","price_per_share":26.2634,"price_display":"26.26","price_state":"stated","total_value":774770.3,"total_display":"774,770.30","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-03","scope":"insider"},{"id":6531454,"accession":"0001209191-14-061878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-061878","line_url":"/filing/0001209191-14-061878#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":27.06,"price_display":"27.06","price_state":"stated","total_value":13530.0,"total_display":"13,530.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-03","scope":"insider"},{"id":6708603,"accession":"0001209191-14-055969","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-055969","line_url":"/filing/0001209191-14-055969#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23033.0,"shares_display":"23,033","price_per_share":33.3464,"price_display":"33.35","price_state":"stated","total_value":768067.6312,"total_display":"768,067.63","shares_owned_after":6967.0,"shares_owned_after_display":"6,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6708600,"accession":"0001209191-14-055969","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-055969","line_url":"/filing/0001209191-14-055969#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6967.0,"shares_display":"6,967","price_per_share":33.85,"price_display":"33.85","price_state":"stated","total_value":235832.95,"total_display":"235,832.95","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6493587,"accession":"0001209191-14-050703","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-050703","line_url":"/filing/0001209191-14-050703#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19820.0,"shares_display":"19,820","price_per_share":29.9643,"price_display":"29.96","price_state":"stated","total_value":593892.426,"total_display":"593,892.43","shares_owned_after":10180.0,"shares_owned_after_display":"10,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-01","filed_date":"2014-08-05","scope":"insider"},{"id":6493585,"accession":"0001209191-14-050703","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-050703","line_url":"/filing/0001209191-14-050703#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10180.0,"shares_display":"10,180","price_per_share":30.7823,"price_display":"30.78","price_state":"stated","total_value":313363.814,"total_display":"313,363.81","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-01","filed_date":"2014-08-05","scope":"insider"},{"id":6912463,"accession":"0001209191-14-046115","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-046115","line_url":"/filing/0001209191-14-046115#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29600.0,"shares_display":"29,600","price_per_share":31.5216,"price_display":"31.52","price_state":"stated","total_value":933039.36,"total_display":"933,039.36","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-03","scope":"insider"},{"id":6912454,"accession":"0001209191-14-046115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-046115","line_url":"/filing/0001209191-14-046115#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":31.89,"price_display":"31.89","price_state":"stated","total_value":12756.0,"total_display":"12,756.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-03","scope":"insider"},{"id":7071718,"accession":"0001209191-14-039092","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-039092","line_url":"/filing/0001209191-14-039092#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577034","owner_name":"Gould Robert J","owner_url":"/insider/0001577034","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28800.0,"shares_display":"28,800","price_per_share":22.1545,"price_display":"22.15","price_state":"stated","total_value":638049.6,"total_display":"638,049.60","shares_owned_after":1200.0,"shares_owned_after_display":"1,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-02","filed_date":"2014-06-04","scope":"insider"}],"next_cursor":"2014-06-02|7071718","ledger_fault":false,"count":{"value":58,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":58,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":58},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001680581","name":"Fulcrum Therapeutics, Inc.","url":"/issuer/0001680581","role":"Director, Officer (Interim President & CEO)","n_filings":21,"first_seen":"2020-02-20","last_seen":"2026-02-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Director, Officer (President & CEO)","n_filings":14,"first_seen":"2014-01-06","last_seen":"2015-12-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001577034","retrieved_at":"2026-08-21T12:10:08+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}